Supply of cDNA Clones Sample Clauses

Supply of cDNA Clones. Upon the written request of Corvas and subject to the grant of license rights as described in Section 3.1, Incyte shall provide to Corvas, one or more isolated cDNA Clones from the LifeSeq(R) Database Product(s) under the following terms and conditions: Shipments usually occur within twelve (12) business days of the receipt of the order. For this service, a fee of [...***...] verified cDNA Clone that is not a Full-Length Clone, and [...***...] per sequence verified cDNA Clone that is a Full-Length Clone, will be payable. If the cDNA Clone cannot be verified, there is no charge and Corvas may request an alternative clone, or request failure analysis on the CDNA Clone at a cost of [...***...] per clone. In failure analysis Incyte will review the clone retrieval process to determine the failure point and proceed to re-process, including searching an entire 96-well plate in the case of gel tracking error or electroporating from master archives if the clone will not transform. There is no refund of the failure analysis fee if Incyte remains unsuccessful in obtaining a verified clone.. Corvas agrees to submit any payments due within thirty (30) days from receipt of invoice from Incyte in reasonably detailed form regarding such clone supply. Corvas agrees that such cDNA Clone(s) are provided to Corvas on a nonexclusive basis and subject to any license(s) granted under Article 3.0.
Sample 1
AutoNDA by SimpleDocs
Supply of cDNA Clones. Upon the written request of GHI and subject to the grant of license rights as described in Section 3.1 and 3.2, Incyte shall provide to GHI, one or more isolated cDNA Clones from the LifeSeq® Database Product(s) under the following terms and conditions: Shipments usually occur within twelve (12) business days of the receipt of the order. For this service, a fee of $*** per verified clone Full Length Clone and $*** per non-Full Length Clone will be payable. If the clone cannot be verified, there is no charge and GHI may request an alternative clone, or request failure analysis on the cDNA Clone at a cost of $*** per clone. In failure analysis Incyte will review the clone retrieval process to determine the failure point and proceed to re-process, including searching an entire 96-well plate in the case of gel tracking error or electroporating from master archives if the clone will not transform. There is no refund of the failure analysis fee if Incyte remains unsuccessful in obtaining a verified clone. GHI agrees to submit any payments due within thirty (30) days from receipt of invoice from Incyte in reasonably detailed form regarding such clone supply. GHI agrees that such cDNA Clone(s) are provided to GHI on a nonexclusive basis and subject to any license(s) granted under Article 3.0.
Sample 1
Supply of cDNA Clones. During the Access Term, Incyte hereby agrees to provide to ARIAD, at ARIAD's option and pursuant to its written request from time to time, one or more isolated cDNAs, corresponding to a given Consensus DNA Sequence in the Database Information and the subject of license(s) granted hereunder this Article 3, at the following rates: [*] ARIAD agrees to submit payments within thirty (30) days from receipt of invoice from Incyte in reasonably detailed form regarding such clone supply. ARIAD agrees that such cDNA Clone(s) are provided to ARIAD on a non-exclusive basis and the subject of license(s) granted under Article 3. No rights under Incyte Patent Rights are granted under this Section 3.8.
Sample 1
Supply of cDNA Clones. 2.5.1 At any time for a period of [...***...] years from the Effective Date, upon written request of Senomyx, and subject to the grant of license rights pursuant to Sections 3.1.1 and 3.1.2, Incyte shall provide Senomyx with up to [...***...] isolated cDNA clones available from Incyte's cDNA clone repository from the LifeSeq-Registered Trademark- Database Product(s) which are Gene Product(s) [...***...] under the terms and conditions (excluding payment) below.
Sample 1
Supply of cDNA Clones. Upon the written request of diaDexus and subject to the grant of license rights as described in Section 3.1 and 3.2, Incyte shall provide to diaDexus, one or more isolated cDNA Clones from the LifeSeq(R) Database Product(s) under the following terms and conditions: Shipments usually occur within twelve (12) business days of the receipt of the order. For this service, a fee of ***** per verified clone will be payable in cases where Incyte has on hand a previously-verified clone, or in cases where diaDexus agrees to accept an alternate clone that Incyte has previously verified. If Incyte does not have on hand a previously-verified clone requested by diaDexus, diaDexus may request that Incyte attempt to sequence and verify a clone, at a cost of ***** per clone, provided that although Incyte shall use professional skill and care in its efforts, the results of any such attempt to sequence and verify a clone in that case will be provided on an "AS IS" basis. diaDexus agrees to submit any payments due within thirty (30) days from receipt of invoice from Incyte in reasonably detailed form regarding such clone supply. diaDexus agrees that such cDNA Clone(s) are provided to diaDexus on a nonexclusive basis and subject to any license(s) granted under Article 3.0.
Sample 1

Related to Supply of cDNA Clones

  • Manufacturing and Supply Genentech shall be responsible for manufacturing and supplying Licensed Products for clinical use and commercial sale in the Genentech Field.

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Manufacturing Agreement Each of the Sellers (as applicable) shall have executed and delivered to the Buyer the Manufacturing Agreement with respect to the portion of the Business conducted at the applicable Facility.

  • Supply of Products TheraSense shall be responsible for the ------------------ manufacture of FreeStyle Products for sale to Nipro.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Supply Agreements For a period of three years from the consummation of the IPO, Odetics shall not unilaterally terminate or assign its guarantee obligation with respect to any supply agreement pursuant to which it has guaranteed the performance by ATL of ATL's obligations, unless such suppliers have consented to the termination or assignment of such guarantee.

  • Supply Agreement Buyer shall have executed and delivered the Supply Agreement to the Company.

  • Manufacturing Intrexon shall have the option and, in the event it so elects, shall use Diligent Efforts, to perform any manufacturing activities in connection with the Aquaculture Program that relate to the Intrexon Materials, including through the use of a suitable Third Party contract manufacturer. To the extent that Intrexon so elects, Intrexon may request that AquaBounty and Intrexon establish and execute a separate manufacturing and supply agreement, which agreement will establish and govern the production, quality assurance, and regulatory activities associated with manufacture of Intrexon Materials. Except as provided in Section 4.1, any manufacturing undertaken by Intrexon pursuant to the preceding sentence shall be performed in exchange for cash payments equal to Intrexon’s Fully Loaded Cost in connection with such manufacturing, on terms to be negotiated by the Parties in good faith. In the event that Intrexon does not manufacture Intrexon Materials or bulk quantities of other components of AquaBounty Products, then Intrexon shall provide to AquaBounty or a contract manufacturer selected by AquaBounty and approved by Intrexon (such approval not to be unreasonably withheld) all Information Controlled by Intrexon that is (a) related to the manufacturing of such Intrexon Materials or bulk qualities of other components of AquaBounty Products for use in the Field and (b) reasonably necessary to enable AquaBounty or such contract manufacturer (as appropriate) for the sole purpose of manufacturing such Intrexon Materials or bulk quantities of other components of AquaBounty Products. The costs and expenses incurred by Intrexon in carrying out such transfer shall be borne by Intrexon. Any manufacturing Information transferred hereunder to AquaBounty or its contract manufacturer shall not be further transferred to any Third Party, including any Product Sublicensee, or any AquaBounty Affiliate without the prior written consent of Intrexon; provided, however, that Intrexon shall not unreasonably withhold such consent if necessary to permit AquaBounty to switch manufacturers.

  • Supply of Product The JDC shall be responsible for determining the sources of, and arrangements for, the manufacture and supply of Products that the JDC believes will result in long-term profit maximization for such Products. The JDC shall endeavor to [ * ].

  • Supply of Materials Unless the parties otherwise agree in a Work Order, Manufacturer will supply, in accordance with the relevant approved raw material specifications, all materials to be used by Manufacturer in the performance of Services under a Work Order other than the Rhythm Materials specified in such Work Order. Rhythm or its designees will provide Manufacturer with the Rhythm Materials. Manufacturer agrees (a) to account for all Rhythm Materials, (b) not to provide Rhythm Materials to any third party (other than an Affiliate acting as a permitted subcontractor) without the express prior written consent of Rhythm, (c) not to use Rhythm Materials for any purpose other than conducting the Services, including, without limitation, not to analyze, characterize, modify or reverse engineer any Rhythm Materials or take any action to determine the structure or composition of any Rhythm Materials unless required * CONFIDENTIAL TREATMENT REQUESTED. OMITTED PORTIONS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. pursuant to a signed Work Order, and (d) to destroy or return to Rhythm all unused quantities of Rhythm Materials according to Rhythm’s written directions.

Time is Money Join Law Insider Premium to draft better contracts faster.